< Back to all clusters
[BUSINESS] · United States, United Kingdom, Italy · 11 sources

started · updated

CNH Industrial and Other Companies Post Strong Q2 2026 Results

CNH Industrial N.V. posted second‑quarter 2026 revenue of $4.80 billion, a 2 % year‑over‑year increase, with adjusted EPS of $0.13 beating estimates. Net income fell to $141 million, but the firm returned $0.2 billion to shareholders and raised its full‑year EPS outlook to $0.41‑$0.46.

GeneDx Holdings Corp. reported Q2 2026 revenue of $114.4 million, driven by a 32 % rise in exome and genome test volume to 30,785. Adjusted net income was $0.4 million and the company reaffirmed full‑year revenue guidance of $475‑$490 million while adding a $50 million term‑loan facility.

Jazz Pharmaceuticals recorded $1.21 billion in Q2 revenue, up 16 % year‑over‑year, and lifted its full‑year revenue target to $4.60‑$4.75 billion. XYWAV sales reached $471 million, while Epidiolex contributed $292 million.

Rivian Automotive achieved a consolidated gross profit of $215 million from its software and services segment, offsetting a $36 million loss in vehicle manufacturing. The company delivered 12,194 vehicles, generated $1.66 billion in revenue and continued construction of a new plant in Georgia.

CNA Financial reported Q2 net income of $321 million, helped by $701 million of investment income. Premiums grew 4 % to $2.97 billion and the insurer highlighted disciplined growth and AI‑driven efficiency initiatives.

Entities

CNA Financial · CNH Industrial N.V. · GeneDx Holdings Corp. · Georgia manufacturing plant · Georgia plant · Gerrit Marx · Jazz Pharmaceuticals · Normal, Illinois · Normal, Illinois facility · R2 electric SUV · R2 electric sport utility vehicle · Rivian Automotive

Claims

What the coverage asserts, and how many sources carry each claim.